Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice
Addressing practical challenges in clinical practice after the recent approvals of amyloid antibodies in Alzheimer's…
CertaraMay 22, 2024
CERTAINTY Europe
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders, and…
CertaraMay 22, 2024
Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies
Targeted radiation therapies (TRT) deliver cytotoxic radiation selectively to tumors. In recent years, oncology drug…
CertaraMay 22, 2024
Demystifying CDISC, SDTM, and ADaM
Breaking down the basics of CDISC’s CDASH, SDTM and ADaM standards, to help you understand…
CertaraMay 22, 2024
Certara Appoints New Chief Human Resources Officer & General Counsel
RADNOR, PA – May 21, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraMay 21, 2024
Accelerating the Progress of Kinase Inhibitors in Oncology
The potential of PBPK modeling in answering key questions around these drugs. Hannah Jones, PhDMasoud…
CertaraMay 20, 2024
Leveling Up SDTM Validation with the Magic of Data Managers
In this abstract, Julie Ann Hood and Jennifer Manzi look at how you can improve…
CertaraMay 19, 2024
Unlocking Efficiency in Formulation Development and Approvals with MIFD & Simcyp Biopharmaceutics [APAC Webinar]
Biopharmaceutical professionals can gain a significant edge in formulation development by attending this free webinar…
CertaraMay 16, 2024
Dreaming big with standardization in clinical trial design – one biopharma’s metadata automation journey
This case study explores how one biopharma gets deeper insights & more informed decision making…
CertaraMay 13, 2024
